MedPath

Long-term Efficacy of Percutaneous Tibial Nerve Stimulation Applied to Patients With Faecal Incontinence.

Completed
Conditions
Faecal Incontinence
Registration Number
NCT05016453
Lead Sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Brief Summary

Percutaneous tibial nerve stimulation (PTNS) is an ambulatory therapy validated for patients with Faecal Incontinence (FI) refractory to conservative treatment with proved short and mid-term efficacy.

The investigators therefore aimed to evaluate the long-term efficacy of PTNS, considered 3 years of follow-up. The investigators also aimed to identify predictors of responses and suggest a new approach for partial responders.

Detailed Description

Prospective single-centre cohort of patients with FI treated with PTNS was analysed.

PTNS sessions were performed in three phases: weekly for three months in the first phase, biweekly for three months in the second phase, and monthly for six months in the third and final phase.

Clinical control at the end of each phase and an additional follow-up was performed at 36 months. Wexner score, faecal urgency, bowel habits and quality of life for FI were assessed.

Patients were categorized in three groups: optimal responders when there was an improvement in Wexner score \> 50%; partial responders if the improvement in Wexner score was 25-50%; and non-responders, when the improvement of Wexner score was \< 25%.

Optimal responders and partial responders progressed into successive phases, whereas non-responders abandoned PTNS and other treatment options were offered.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
139
Inclusion Criteria
  • Diagnosis of faecal incontinence for more than 6 months, refractory to conservative treatment.
Exclusion Criteria
  • Anatomic injuries that require surgery.
  • External anal sphincter lesion of > 180º.
  • Unavailability to attend regularly outpatient clinic.
  • Major psychologic or psychiatric comorbidities

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in faecal incontinence assessed by Wexner ScoreBaseline compared to 3, 6, 12 and 36 months after start of PTNS

Rate of patients with improvement in faecal incontinence assessed by Wexner score (Maximum punctuation: 20 being severe incontinence. Minimum punctuation: 0, no incontinence).

Secondary Outcome Measures
NameTimeMethod
Predictors of good long-term improvement in Wexner scoreAt 3, 6 and 12 months after start of PTNS

Influence of previous obstetric or surgery history and duration of symptoms in the variation of Wexner score

Partial RespondersAt 3, 6 and12 months after start of PTNS

Incidence of patients with a decrease in Wexner score between 25 and 50% compared to initial value, and their performance in the long term

Trial Locations

Locations (1)

Hospital General Universitario de Elche

🇪🇸

Elche, Alicante, Spain

© Copyright 2025. All Rights Reserved by MedPath